Skelaxin
Product Images NDC 10544-524

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Skelaxin (NDC 10544-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

800mg 20ct (Label Slelaxin Tabs 800mg Bpi(10544 524 20) King(60793 136 05) Rev1)

SKELAXIN (metaxalone) Tablets, 800 mg, pharmaceutical label showing packaging details for 20 tablets. Label includes prescription only status, storage instructions, manufacturer Blenheim Pharmacal, Inc., and barcodes. The design features black text on a white background with a yellow border.*

FDA Label Image

Structure (Skelaxin 01)

Chemical structure of Methocarbamol, the active ingredient in SKELAXIN. The diagram shows the molecular arrangement including functional groups and bonds in the compound.*

FDA Label Image

Figure 1 (Skelaxin 02)

A line graph depicting mean concentrations of Metaxalone over 12 hours following an 800 mg dose under fasted and fed conditions. Concentration (ng/mL) is plotted on the vertical axis, and time (hours) on the horizontal axis. Two curves show higher Metaxalone concentrations with food compared to fasting, with error bars indicating standard deviation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.